HoneyNaps is a 'Sleep-Tech' company specializing in artificial intelligence (AI) sleep data analysis. They won FDA approval for their AI-powered SOMNUM sleep diagnosis software in 2023. The software analyzes bio signal data during sleep and provides disease diagnoses under five minutes using its self-developed AI model. This AI diagnosis software is integrable into any medical and healthcare market using real-time large-scale bio signal.
Market
Healthcare
Location
Seoul,
South Korea
Coinvestors
Korea Industrial Bank, Hi Investment Partners, QUAD Investment Management